Aphria (TSE:APH) – Equities researchers at Clarus Securities raised their FY2018 earnings per share (EPS) estimates for shares of Aphria in a research report issued on Tuesday, April 17th. Clarus Securities analyst N. Atkinson now expects that the company will post earnings of $0.19 per share for the year, up from their prior forecast of $0.12. Clarus Securities also issued estimates for Aphria’s FY2019 earnings at $0.20 EPS and FY2020 earnings at $1.55 EPS.
A number of other brokerages have also issued reports on APH. Canaccord Genuity set a C$23.00 price target on Aphria and gave the stock a “speculative buy” rating in a research note on Thursday, January 11th. Pi Financial raised their price objective on Aphria from C$14.00 to C$25.00 in a report on Thursday, January 11th.
Shares of APH stock opened at C$11.00 on Thursday. Aphria has a 52-week low of C$4.55 and a 52-week high of C$24.75.
WARNING: This story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/20/fy2018-earnings-forecast-for-aphria-issued-by-clarus-securities-aph.html.
Aphria Company Profile
Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.